泌尿系统
塔姆-霍斯法尔蛋白
蛋白质组
糖基化
糖尿病
蛋白质组学
脂质运载蛋白
生物标志物
血糖性
生物
微生物群
内科学
医学
生物信息学
内分泌学
基因
生物化学
作者
Harinder Singh,Yonghao Yu,Moo-Jin Suh,Manolito Torralba,Robert D. Stenzel,Andrey Tovchigrechko,Vishal Thovarai,Derek M. Harkins,Seesandra V. Rajagopala,Whitney Osborne,Fran R. Cogen,Paul B. Kaplowitz,Karen E. Nelson,Ramana Madupu,Rembert Pieper
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2017-01-01
卷期号:7 (10): 2704-2717
被引量:27
摘要
While insulin replacement therapy restores the health and prevents the onset of diabetic complications (DC) for many decades, some T1D patients have elevated hemoglobin A1c values suggesting poor glycemic control, a risk factor of DC. We surveyed the stool microbiome and urinary proteome of a cohort of 220 adolescents and children, half of which had lived with T1D for an average of 7 years and half of which were healthy siblings. Phylogenetic analysis of the 16S rRNA gene did not reveal significant differences in gut microbial alpha-diversity comparing the two cohorts. The urinary proteome of T1D patients revealed increased abundances of several lysosomal proteins that correlated with elevated HbA1c values. In silico protein network analysis linked such proteins to extracellular matrix components and the glycoprotein LRG1. LRG1 is a prominent inflammation and neovascularization biomarker. We hypothesize that these changes implicate aberrant glycation of macromolecules that alter lysosomal function and metabolism in renal tubular epithelial cells, cells that line part of the upper urinary tract.
科研通智能强力驱动
Strongly Powered by AbleSci AI